Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study

Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study

Glioblastoma (GBM) is the most common and aggressive type of tumour arising from the central nervous system. GBM remains an incurable disease despite advancement in therapies, with overall survival of approximately 15 months. Recent literature has highlighted that GBM releases tumoural content which...

Full description

Bibliographic Details
Main Authors: Juliana Müller Bark, Arutha Kulasinghe, Gunter Hartel, Paul Leo, Majid Ebrahimi Warkiani, Rosalind L. Jeffree, Benjamin Chua, Bryan W. Day, Chamindie Punyadeera
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
liquid biopsy
circulating tumour cells
glioma
spiral microfluidic technology
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.681130/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.681130/full

Similar Items